{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3830, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a chevron-based layout to categorize key company pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/5", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-5", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 6, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/6", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-6", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "ad576464-d783-4af6-b425-f8685860a497", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 6-7 present team information", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 7, "slideType": "team_bio", "function": "other", "notes": "The slide is split into two sections: individual board member profiles and a grid of investor logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/7", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-7", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "ad576464-d783-4af6-b425-f8685860a497", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slides 6-7 present team information", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a Gantt-style visualization to represent clinical trial phases for different indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/8", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-8", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 9, "slideType": "market_sizing", "function": "size_opportunity", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/9", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-9", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 9, "from": 9, "beatId": "90b278ba-14fd-46df-ab28-dbf89276c85e", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 9 presents market sizing information", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 10, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a Kaplan-Meier curve to visually demonstrate the 'problem' (rapid progression) and a callout box to quantify the market opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/10", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-10", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 10, "from": 10, "beatId": "a9f20cbe-143f-496d-bc90-e53c6de8c8f4", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slide 10 presents the problem statement", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 11, "slideType": "section_divider", "function": "transition", "notes": "The slide features a stylized 3D rendering of a cell, likely representing the therapeutic target or mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/11", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-11", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Includes Kaplan-Meier survival curves and a summary table of clinical outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/12", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-12", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 12, "beatId": "2e0a910a-dd04-43c7-b080-55652ca53d9d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 12-15 present traction and results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 13, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the clinical trial stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/13", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-13", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 12, "beatId": "2e0a910a-dd04-43c7-b080-55652ca53d9d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 12-15 present traction and results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 14, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide uses a comparison table to contrast clinical trial data for CRG-022 against historical benchmarks for ZUMA-1, JULIET, and TRANSCEND.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/14", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-14", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 12, "beatId": "2e0a910a-dd04-43c7-b080-55652ca53d9d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 12-15 present traction and results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 15, "slideType": "traction", "function": "show_traction", "notes": "Kaplan-Meier survival curve shown.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/15", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-15", "loopMatches": [ { "to": 15, "from": 10, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "1e639289-7657-46f8-9306-fe7898bf6a06", "evidence": "The loop is opened on slide 10 and closed on slides 12-15", "position": 0, "objective": "What is the cost of not addressing the unmet need for LBCL patients whose disease is R/R to CD19 CAR T-cell therapy?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 12, "beatId": "2e0a910a-dd04-43c7-b080-55652ca53d9d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 12-15 present traction and results", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 16, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines the methodology for a clinical trial, specifically detailing the patient population and treatment protocol.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/16", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-16", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 17, "slideType": "comparison_table", "function": "present_framework", "notes": "The table uses checkmarks to indicate which strategic principles impact specific operational metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/17", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-17", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 18, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological schematic to explain the mechanism of action and key design features of the therapeutic candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/18", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-18", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 18, "from": 18, "beatId": "0b7c883f-3725-4066-9502-b130398fca42", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slide 18 presents the solution overview", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 19, "slideType": "section_divider", "function": "transition", "notes": "Features a stylized 3D rendering of a cell, likely representing CAR-T or similar cellular therapy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/19", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-19", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 20, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a problem-solution mapping framework to explain the therapeutic approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/20", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-20", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 21, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a biological mechanism diagram, a Kaplan-Meier survival curve, and IHC images to demonstrate the clinical impact of CD58 loss.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/21", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-21", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 22, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/22", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-22", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 23, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a funnel diagram to represent the screening process and bar charts to demonstrate specificity across CD19, CD20, and CD22 targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/23", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-23", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 24, "slideType": "traction", "function": "show_traction", "notes": "Data shows bioluminescent flux over time; CRG-023 consistently reduces tumor burden to baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/24", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-24", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 25, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/25", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-25", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 26, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a matrix structure to categorize therapies by modality and development stage, highlighting CARGO's specific positioning.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/26", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-26", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/27", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-27", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 28, "slideType": "executive_summary", "function": "summarize", "notes": "Includes investor logos, financial metrics, and a timeline of clinical milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/28", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-28", "loopMatches": [ { "to": 28, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "f28bc1f0-250a-416d-b5fe-d9a40f469b97", "evidence": "The loop is opened on slide 4 and closed on slide 28", "position": 1, "objective": "Why does CARGO Therapeutics exist? What is the company's vision?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f8dc-71cb-8c77-d8d892e68e05", "docSlug": "d63a60a343bcaadeb9fd5627a42c66c9", "documentTitle": "CARGO Therapeutics | IPO Presentation Deck | 29 slides", "authorId": "cargo-therapeutics", "authorName": "CARGO Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7794254, "pageNumber": 29, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f8dc-71cb-8c77-d8d892e68e05/29", "deckHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05", "deckAnchorHref": "/decks/019de076-f8dc-71cb-8c77-d8d892e68e05#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/vrB3ZxvyDUSvCpKrQHdE-g6GaikpH6KjYCeVbeCu-5E/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMDJhMWQxY2I3NTU3YmM0MzBjYzhkYzYxY2QyNzA5Ny9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/1", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/xTtbRSQx77lhpdUblx_j-1IHooArGHaRxSnAVBdkrLw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMDJhMWQxY2I3NTU3YmM0MzBjYzhkYzYxY2QyNzA5Ny9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Njzvcc_WDdKmIEZUXrER-qoT78UmVF9J1USknNEkh8U/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMDJhMWQxY2I3NTU3YmM0MzBjYzhkYzYxY2QyNzA5Ny9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/FfEwaZf72B7zXolORul7xOumBq6wb2BxfJCAxSX7zJU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jMDJhMWQxY2I3NTU3YmM0MzBjYzhkYzYxY2QyNzA5Ny9wMDAxLnBuZw" }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 2, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/2", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 3, "slideType": "appendix_data", "function": "other", "notes": "This is a standard IPO 'deal terms' slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/3", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid layout for five executive profiles, each including a headshot, title, brief bio, and relevant company logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/4", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 4, "from": 4, "beatId": "775c68ee-ea8d-4dc0-a2ea-df826647911b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "Slide 4 presents the team: 'The CG Oncology Team'.", "position": 4, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 5, "slideType": "mission", "function": "inspire_vision", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/5", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 6, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/6", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "Uses a comparative diagram to illustrate the biological mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/7", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "1146c958-c0a9-4157-948d-c4acb745bb2f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 present the solution: 'Cretostimogene Grenadenorepvec Selectively Targets Rb-Pathway Defective Cancers' and its mechanism of action.", "position": 1, "confidence": 0.9, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a circular process diagram overlaid on a cross-section of a bladder to explain the treatment steps.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/8", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "1146c958-c0a9-4157-948d-c4acb745bb2f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 present the solution: 'Cretostimogene Grenadenorepvec Selectively Targets Rb-Pathway Defective Cancers' and its mechanism of action.", "position": 1, "confidence": 0.9, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 9, "slideType": "solution", "function": "present_solution", "notes": "Uses a before-after framing to explain the mechanism of action for the DDM surfactant.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/9", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "1146c958-c0a9-4157-948d-c4acb745bb2f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 present the solution: 'Cretostimogene Grenadenorepvec Selectively Targets Rb-Pathway Defective Cancers' and its mechanism of action.", "position": 1, "confidence": 0.9, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process flow to explain the therapeutic mechanism.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/10", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 10, "from": 7, "beatId": "1146c958-c0a9-4157-948d-c4acb745bb2f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "Slides 7-10 present the solution: 'Cretostimogene Grenadenorepvec Selectively Targets Rb-Pathway Defective Cancers' and its mechanism of action.", "position": 1, "confidence": 0.9, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 11, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a three-column layout to categorize the problem into prevalence, clinical challenges, and patient profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/11", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-11", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 11, "from": 11, "beatId": "0adde54f-802c-40f0-abcd-b53c30e2638d", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "Slide 11 presents the problem statement: 'Bladder Cancer is a Significant Unmet Medical Need Well Positioned for Innovation and Disruption'.", "position": 0, "confidence": 0.9, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 12, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the progression of tumor invasion through the bladder wall layers (Lamina Propria, Inner Muscle, Deep Muscle).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/12", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-12", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 12, "beatId": "50c2fbcb-05ac-4d58-a744-24fa6678ee39", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "Slide 12 presents the market sizing: 'NMIBC Represents a Multi-Billion Dollar Market Opportunity in Bladder Cancer'.", "position": 2, "confidence": 0.9, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 13, "slideType": "customer_journey", "function": "present_framework", "notes": "The slide uses a process flow that transitions into a decision tree/matrix based on risk levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/13", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-13", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" }, { "to": 15, "from": 13, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "6f9edf1b-df40-4ee7-a622-285d4d2d2fff", "evidence": "The loop is opened on slide 13 ('The Patient Journey') and closed on slide 15 ('Focused Execution Towards Becoming the Leader in High-Risk and Intermediate-Risk Markets').", "position": 1, "objective": "What are the needs of patients with bladder cancer?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 14, "slideType": "why_now", "function": "argue_timing", "notes": "The slide highlights the regulatory environment as a key driver for development, citing specific FDA definitions and successful approvals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/14", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-14", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" }, { "to": 15, "from": 13, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "6f9edf1b-df40-4ee7-a622-285d4d2d2fff", "evidence": "The loop is opened on slide 13 ('The Patient Journey') and closed on slide 15 ('Focused Execution Towards Becoming the Leader in High-Risk and Intermediate-Risk Markets').", "position": 1, "objective": "What are the needs of patients with bladder cancer?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 15, "slideType": "segmentation", "function": "decompose_segments", "notes": "The slide uses a hierarchical tree structure to map clinical trials to specific patient segments (Intermediate vs High Risk, BCG-naïve/exposed/unresponsive).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/15", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-15", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" }, { "to": 15, "from": 13, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "6f9edf1b-df40-4ee7-a622-285d4d2d2fff", "evidence": "The loop is opened on slide 13 ('The Patient Journey') and closed on slide 15 ('Focused Execution Towards Becoming the Leader in High-Risk and Intermediate-Risk Markets').", "position": 1, "objective": "What are the needs of patients with bladder cancer?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 16, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "Includes FDA Fast Track and Breakthrough Therapy designations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/16", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-16", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "BOND-003 study data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/17", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-17", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Efficacy data cutoff as of October 5, 2023. Footnote indicates some patients excluded from 6-month assessment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/18", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-18", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 19, "from": 18, "beatId": "d913ba4c-a659-4d05-87f0-7e206fb35199", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 18-19 present traction: 'First Results From BOND-003: 75.7% CR at Any Time' and 'SUO 2023: First Results from BOND-003'.", "position": 3, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a swimmer plot to visualize individual patient response durations, including complete response, recurrence, and reinduction events.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/19", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-19", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 19, "from": 18, "beatId": "d913ba4c-a659-4d05-87f0-7e206fb35199", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 18-19 present traction: 'First Results From BOND-003: 75.7% CR at Any Time' and 'SUO 2023: First Results from BOND-003'.", "position": 3, "confidence": 0.9, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "BOND-003 clinical trial safety data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/20", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-20", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 21, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide explicitly notes that these are not head-to-head studies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/21", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-21", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 22, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process-flow style layout to define the clinical trial parameters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/22", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-22", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 23, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a swimmer plot to visualize patient-level clinical trial data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/23", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-23", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table lists specific medical conditions (Preferred Terms) and their occurrence rates across 35 patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/24", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-24", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 25, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/25", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-25", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 26, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "PIVOT-006 trial design slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/26", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-26", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 27, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide uses a process-flow layout to define the clinical trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/27", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-27", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 28, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a hierarchical tree structure to map patient risk categories to specific clinical trial programs (PIVOT-006, CORE-008, BOND-003, CORE-001).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/28", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-28", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 29, "slideType": "other", "function": "plan_implementation", "notes": "CMC stands for Chemistry, Manufacturing, and Controls.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/29", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-29", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 30, "slideType": "team_bio", "function": "other", "notes": "The slide uses a grid of four headshots with biographical details and company logos for each member.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/30", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-30", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 31, "slideType": "go_to_market", "function": "plan_implementation", "notes": "The slide uses a circular process flow graphic to represent a sequential commercialization strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/31", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-31", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 32, "slideType": "go_to_market", "function": "plan_implementation", "notes": "The diagram uses a hub-and-spoke model to show how various commercial roles interact with the central customer entities (LUGPA and Hospitals).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/32", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-32", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 33, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a grid-based timeline layout to map specific clinical trial milestones (stars) against time periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/33", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-33", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 34, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/34", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-34", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-f978-76c3-9c95-6b6ce7102162", "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097", "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides", "authorId": "cg-oncology", "authorName": "CG Oncology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7761332, "pageNumber": 35, "slideType": "cover", "function": "front_matter", "notes": "This is a standard contact/footer slide often found at the end of a pitch deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/35", "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162", "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-35", "loopMatches": [ { "to": 40, "from": 11, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "a5790f76-8d5a-4a24-8439-7cae53e211ed", "evidence": "The loop is opened on slide 11 ('Bladder Cancer is a Significant Unmet Medical Need') and closed on slide 40 ('Intermediate-Risk & High-Risk Patients Need More Options to Get Better Outcomes').", "position": 0, "objective": "What are the consequences of not adopting Cretostimogene?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.8, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }